CCL28 and colorectal carcinoma: To explore the role of CCL28-induced immunosuppression in BF BSH-accelerated CRC, anti-CCL28 or anti-CD25 neutralizing antibody were applied to block CCL28 or CD25+FOXP3+ Treg cells27,28.